• Explore /
  • Poster
  • / Phase 1 study to evaluate safety and preliminary efficacy of padeliporfin vascular targeted photodynamic therapy (VTP) in patients with locally advanced (LA) unresectable pancreatic ductal adenocarcinoma (PDAC).

Phase 1 study to evaluate safety and preliminary efficacy of padeliporfin vascular targeted photodynamic therapy (VTP) in patients with locally advanced (LA) unresectable pancreatic ductal adenocarcinoma (PDAC).

Abstract Poster

Authors

Nadine Abi-Jaoudeh

Nadine Abi-Jaoudeh

University of California Irvine, Division of Vascular & Interventional Radiology, Department of Radiological Sciences, Orange, CA

Nadine Abi-Jaoudeh , Jennifer Brooke Valerin , David K Imagawa , Dina Preise , Zachary Sacks , Yaniv Cohen , Julia Rothman , Keren Brook , Eyal Morag , Avigdor Joshua Scherz , Inna Krasnopolskaya , Genia Alpert , Vincent Chung , Laleh Golkar Melstrom , Jonathan Kessler

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer - Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT5918783

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS4204)

DOI

10.1200/JCO.2024.42.16_suppl.TPS4204

Abstract #

TPS4204

Poster Bd #

172a

Abstract Disclosures

Similar Posters

First Author: Heloisa P. Soares

First Author: Joon Oh Park

First Author: Anthony B. El-Khoueiry

First Author: Mitesh J. Borad